These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 17168239

  • 1. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].
    Martínez-Bisbal MC, Arana E, Martí-Bonmatí L, Martínez-Granados B, Celda B.
    Radiologia; 2006; 48(5):301-7. PubMed ID: 17168239
    [Abstract] [Full Text] [Related]

  • 2. Cognitive impairment: classification by 1H magnetic resonance spectroscopy.
    Martínez-Bisbal MC, Arana E, Martí-Bonmatí L, Mollá E, Celda B.
    Eur J Neurol; 2004 Mar; 11(3):187-93. PubMed ID: 15009164
    [Abstract] [Full Text] [Related]

  • 3. [Dementias: diagnostic contribution of imaging and proton magnetic resonance spectroscopy].
    Arana E, Martínez-Granados B, Marti-Bonmati L, Martínez-Bisbal MC, Gil A, Blasco C, Celda B.
    Neurologia; 2007 Jun; 22(5):267-74. PubMed ID: 17508300
    [Abstract] [Full Text] [Related]

  • 4. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z, Zhao C, Yu L, Zhou W, Li K.
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [Abstract] [Full Text] [Related]

  • 5. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia.
    Fayed N, Dávila J, Oliveros A, Castillo J, Medrano JJ.
    Acad Radiol; 2008 Sep; 15(9):1089-98. PubMed ID: 18692749
    [Abstract] [Full Text] [Related]

  • 6. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
    Fayed N, Dávila J, Oliveros A, Medrano J, Castillo J.
    Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
    [Abstract] [Full Text] [Related]

  • 7. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM, Gavrila D, Antúnez C, Tormo MJ, Salmerón D, Carles R, Jiménez Veiga J, Parrilla G, Torres del Río S, Fortuna L, Navarro C.
    Dement Geriatr Cogn Disord; 2008 Mar; 26(1):15-25. PubMed ID: 18566544
    [Abstract] [Full Text] [Related]

  • 8. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T, Xiao S, Li X, Ding B, Ling H, Chen K, Fang Y.
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [Abstract] [Full Text] [Related]

  • 9. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
    Waldman AD, Rai GS.
    Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326
    [Abstract] [Full Text] [Related]

  • 10. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.
    Kantarci K, Jack CR, Xu YC, Campeau NG, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC.
    Neurology; 2000 Jul 25; 55(2):210-7. PubMed ID: 10908893
    [Abstract] [Full Text] [Related]

  • 11. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
    Targosz-Gajniak MG, Siuda JS, Wicher MM, Banasik TJ, Bujak MA, Augusciak-Duma AM, Opala G.
    J Neurol Sci; 2013 Dec 15; 335(1-2):58-63. PubMed ID: 24035276
    [Abstract] [Full Text] [Related]

  • 12. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec 15; 28(8):1313-22. PubMed ID: 15588758
    [Abstract] [Full Text] [Related]

  • 13. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Weiss U, Bacher R, Vonbank H, Kemmler G, Lingg A, Marksteiner J.
    J Clin Psychiatry; 2003 Mar 15; 64(3):235-42. PubMed ID: 12716263
    [Abstract] [Full Text] [Related]

  • 14. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].
    Wang T, Xiao SF, Li X, Wang Y, Ding B, Ling HW, Chen KM.
    Zhonghua Yi Xue Za Zhi; 2009 Jan 06; 89(1):37-40. PubMed ID: 19489242
    [Abstract] [Full Text] [Related]

  • 15. 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease.
    Kantarci K, Smith GE, Ivnik RJ, Petersen RC, Boeve BF, Knopman DS, Tangalos EG, Jack CR.
    J Int Neuropsychol Soc; 2002 Nov 06; 8(7):934-42. PubMed ID: 12405545
    [Abstract] [Full Text] [Related]

  • 16. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
    Jones RS, Waldman AD.
    Neurol Res; 2004 Jul 06; 26(5):488-95. PubMed ID: 15265265
    [Abstract] [Full Text] [Related]

  • 17. Common 1H-MRS Characteristics in Patients With Alzheimer's Disease and Vascular Dementia Diagnosed With Kidney Essence Deficiency Syndrome: A Preliminary Study.
    Guo Z, Liu X, Cao Y, Hou H, Chen X, Chen Y, Huang F, Chen W.
    Altern Ther Health Med; 2017 May 06; 23(3):12-18. PubMed ID: 28236618
    [Abstract] [Full Text] [Related]

  • 18. (1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer's disease.
    Guo Z, Liu X, Hou H, Wei F, Chen X, Shen Y, Chen W.
    Compr Psychiatry; 2016 Aug 06; 69():179-85. PubMed ID: 27423359
    [Abstract] [Full Text] [Related]

  • 19. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.
    Londono AC, Castellanos FX, Arbelaez A, Ruiz A, Aguirre-Acevedo DC, Richardson AM, Easteal S, Lidbury BA, Arcos-Burgos M, Lopera F.
    Alzheimers Dement; 2014 Sep 06; 10(5):552-61. PubMed ID: 24239247
    [Abstract] [Full Text] [Related]

  • 20. [Cerebral metabolism in patients with cognitive disorders: a combined MRS and PET study].
    Khomenko YG, Kataeva GV, Bogdan AA, Chernysheva EM, Susin DS.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019 Sep 06; 119(1):51-58. PubMed ID: 30778031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.